This information was published on 2026-06-03T11:52:13 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2651090 (IR 1916459) |
| (220) |
30 Mar 2026
|
| (300) |
US, 30 Sep 2025, 99421141
|
| (511) (510) |
Class 1
Biologically derived ingredients and nanoparticles, namely, exosomes and extracellular vesicles for use in the formulation and manufacture of injectable biologic drug preparations. |
| (540) | REGENOSOME |
| (550) | Word |
| (730) |
Rion Medical Aesthetics Inc.
|
Find out more about publications on the About page.